ScholarLens Back to search
2009•Biaoji mianyi fenxi yu linchuangRequires access

Auxiliary Diagnosis Value of Squamous Cell Carcinoma Antigen in Malignant and Benign Diseases

Dong Zhen-nan

Open publisher page 0 citations

Abstract

To investigate the proportion of increasing squamous cell carcinoma antigen(SCCAg) in patients with inflammation and tumor,in order to explore its auxiliary diagnosis for clinic,the data of 300 increasing SCCAg patients in hospital from January to April in 2008 were analyzed retrospectively with CHISS.The results showed that the patients with tumor were 68% and the non-tumor patients were 32% in all 300 increasing SCCAg samples.The values of SCCAg increased had significantly statistics difference in two groups(P0.01),especially in the range of 3.6~5.0 ng/mL(P0.05).The increasing SCCAg had much more significance in tumor patients than non-tumors patients.The SCCAg in the range of 3.6~5.0 ng/mL could be used to differentiate patients with tumors and without tumors.The SCCAg was not a specific tumor marks,could be also increased in non tumor patients.

About this research paper

What this paper is about

To investigate the proportion of increasing squamous cell carcinoma antigen(SCCAg) in patients with inflammation and tumor,in order to explore its auxiliary diagnosis for clinic,the data of 300 increasing SCCAg patients in hospital from January to April in 2008 were analyzed retrospectively with CHISS.The results showed that the patients with tumor were 68% and the non-tumor patients were 32% in all 300 increasing SCCAg samples.The values of SCCAg increased had significantly statistics difference in two groups(P0.01),especially in the range of 3.6~5.0 ng/mL(P0.05).The increasing SCCAg had much more significance in tumor patients than non-tumors patients.The SCCAg in the range of 3.6~5.0 ng/mL could be used to differentiate patients with tumors and without tumors.The SCCAg was not a specific tumor marks,could be also increased in non tumor patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To investigate the proportion of increasing squamous cell carcinoma antigen(SCCAg) in patients with inflammation and tumor,in order to explore its auxiliary diagnosis for clinic,the data of 300 increasing SCCAg patients in hospital from January to April in 2008 were analyzed retrospectively with CHISS.The results showed that the patients with tumor were 68% and the non-tumor patients were 32% in all 300 increasing SCCAg samples.The values of SCCAg increased had significantly statistics difference in two groups(P0.01),especially in the range of 3.6~5.0 ng/mL(P0.05).The increasing SCCAg had much more significance in tumor patients than non-tumors patients.The SCCAg in the range of 3.6~5.0 ng/mL could be used to differentiate patients with tumors and without tumors.The SCCAg was not a specific tumor marks,could be also increased in non tumor patients.

Key concepts: Medicine, Basal cell, Internal medicine, Oncology, Antigen, Immunology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Auxiliary Diagnosis Value of Squamous Cell Carcinoma Antigen in Malignant and Benign Diseases — Research Paper | ScholarLens